Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The first steps towards the era of personalised vaccinology: predicting adverse reactions

Abstract

Until now, the occurrence of adverse reactions among individuals inoculated with identical vaccines has been ascribed to unpredictable stochastic processes. Recent advances in pharmacogenomics indicate that some features of host response to immunisation are influenced by genetic traits, henceforth predictable. The ability to predict the adverse reaction to vaccination would represent an important step towards the development of personalised vaccinology and could enhance public confidence in the safety of vaccines. Herein, we have reviewed all the available information on the association between genetic variants and the risk for healthy subjects to develop adverse reactions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S et al. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2012; 30: 7253–7259.

    Article  PubMed  Google Scholar 

  2. Poland GA, Jacobson RM . The age-old struggle against the antivaccinationists. N Engl J Med 2011; 364: 97–99.

    Article  CAS  PubMed  Google Scholar 

  3. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T et al. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States. Eur J Clin Microbiol Infect Dis 2014; 33: 1519–1524.

    Article  CAS  PubMed  Google Scholar 

  4. Pellegrino P, Carnovale C, Pozzi M, Antoniazzi S, Perrone V, Salvati D et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev 2014; 13: 736–741.

    Article  CAS  PubMed  Google Scholar 

  5. Poland GA, Kennedy RB, Ovsyannikova IG . Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? PLoS Pathog 2011; 7: e1002344.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Crowe JE Jr . Genetic predisposition for adverse events after vaccination. J Infect Dis 2007; 196: 176–177.

    Article  PubMed  Google Scholar 

  7. Jacobson RM, Ovsyannikova IG, Targonski PV, Poland GA . Studies of twins in vaccinology. Vaccine 2007; 25: 3160–3164.

    Article  PubMed  Google Scholar 

  8. Black FL, Hierholzer W, Woodall JP, Pinhiero F . Intensified reactions to measles vaccine in unexposed populations of American Indians. J Infect Dis 1971; 124: 306–317.

    Article  CAS  PubMed  Google Scholar 

  9. Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE Jr . Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J Infect Dis 2004; 189: 1401–1410.

    Article  CAS  PubMed  Google Scholar 

  10. McKinney BA, Reif DM, Rock MT, Edwards KM, Kingsmore SF, Moore JH et al. Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis 2006; 194: 444–453.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358: 568–579.

    Article  PubMed  Google Scholar 

  12. Mitchell LA, Tingle AJ, MacWilliam L, Horne C, Keown P, Gaur LK et al. HLA-DR class II associations with rubella vaccine-induced joint manifestations. J Infect Dis 1998; 177: 5–12.

    Article  CAS  PubMed  Google Scholar 

  13. Stanley SL Jr, Frey SE, Taillon-Miller P, Guo J, Miller RD, Koboldt DC et al. The immunogenetics of smallpox vaccination. J Infect Dis 2007; 196: 212–219.

    Article  CAS  PubMed  Google Scholar 

  14. Reif DM, McKinney BA, Motsinger AA, Chanock SJ, Edwards KM, Rock MT et al. Genetic basis for adverse events after smallpox vaccination. J Infect Dis 2008; 198: 16–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Shaklee JF, Talbot TR, Muldowney JA 3rd, Vaughan DE, Butler J, House F et al. Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events. J Infect Dis 2005; 191: 724–730.

    Article  CAS  PubMed  Google Scholar 

  16. Reif DM, Motsinger-Reif AA, McKinney BA, Rock MT, Crowe JE Jr., Moore JH . Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination. Genes Immun 2009; 10: 112–119.

    Article  CAS  PubMed  Google Scholar 

  17. Chen CC, Schwender H, Keith J, Nunkesser R, Mengersen K, Macrossan P . Methods for identifying SNP interactions: a review on variations of Logic Regression, Random Forest and Bayesian logistic regression. IEEE/ACM Trans Comput Biol Bioinform 2011; 8: 1580–1591.

    Article  PubMed  Google Scholar 

  18. Miller EK, Dumitrescu L, Cupp C, Dorris S, Taylor S, Sparks R et al. Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age. Vaccine 2011; 29: 3431–3437.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM et al. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination. Viral Immunol 2012; 25: 29–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM et al. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine 2011; 29: 7883–7895.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Radice S et al. Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies. Vaccine 2014; 32: 4730–4735.

    Article  PubMed  Google Scholar 

  22. Klein SL, Poland GA . Personalized vaccinology: one size and dose might not fit both sexes. Vaccine 2013; 31: 2599–2600.

    Article  PubMed  Google Scholar 

  23. Pondo T, Rose CE Jr, Martin SW, Keitel WA, Keyserling HL, Babcock J et al. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Vaccine 2014; 32: 3548–3554.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pellegrino P, Carnovale C, Borsadoli C, Danini T, Speziali A, Perrone V et al. Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol. Eur J Clin Pharmacol 2013; 69: 1615–1616.

    Article  PubMed  Google Scholar 

  25. Pellegrino P, Clementi E, Radice S . Infections, vaccinations, drugs and interactions. Eur J Clin Pharmacol 2014; 70: 891–892.

    Article  PubMed  Google Scholar 

  26. Jacobson RM, Targonski PV, Poland GA . A taxonomy of reasoning flaws in the anti-vaccine movement. Vaccine 2007; 25: 3146–3152.

    Article  PubMed  Google Scholar 

  27. Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E et al. Can HPV immunisation cause ADEM? Two case reports and literature review. Mult Scler 2014; 20: 762–763.

    Article  PubMed  Google Scholar 

  28. Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Clementi E et al. Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems. PloS one 2013; 8: e77766.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T et al. On the possible interaction between vaccines and drugs. Eur J Clin Pharmacol 2014; 70: 369–371.

    Article  PubMed  Google Scholar 

  30. Pellegrino P, Carnovale C, Radice S, Clementi E . Influenza-like illness after yellow fever vaccination. J Clin Virol 2014; 60: 181.

    Article  PubMed  Google Scholar 

  31. Shoenfeld Y, Agmon-Levin N . 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4–8.

    Article  CAS  PubMed  Google Scholar 

  32. Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y . Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases. Lupus 2012; 21: 146–152.

    Article  CAS  PubMed  Google Scholar 

  33. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Antoniazzi S et al. Human papillomavirus vaccine in patients with systemic lupus erythematosus. Epidemiology 2014; 25: 155–156.

    Article  PubMed  Google Scholar 

  34. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T et al. On the association between human papillomavirus vaccine and primary ovarian failure. Am J Reprod Immunol 2014; 71: 293–294.

    Article  PubMed  Google Scholar 

  35. Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y . Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 2013; 47: 1–16.

    Article  CAS  PubMed  Google Scholar 

  36. Perricone C, Shoenfeld Y . Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia). J Clin Rheumatol 2013; 19: 231–233.

    Article  PubMed  Google Scholar 

  37. Albert MR, Ostheimer KG, Breman JG . The last smallpox epidemic in Boston and the vaccination controversy, 1901-1903. N Engl J Med 2001; 344: 375–379.

    Article  CAS  PubMed  Google Scholar 

  38. Wolfe RM, Sharp LK . Anti-vaccinationists past and present. BMJ 2002; 325: 430–432.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Watanabe M, Nagai M . Acellular pertussis vaccines in Japan: past, present and future. Expert Rev Vaccines 2005; 4: 173–184.

    Article  PubMed  Google Scholar 

  40. Amirthalingam G, Gupta S, Campbell H . Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill 2013; 18:pii: 20587.

    Article  Google Scholar 

  41. Hauben M, Sakaguchi M, Patadia V, Gerrits CM . Hepatitis B vaccination and multiple sclerosis: a data mining perspective. Pharmacoepidemiol Drug Saf 2007; 16: 943–945.

    Article  PubMed  Google Scholar 

  42. Destefano F, Weintraub ES, Chen RT . Hepatitis B vaccine and risk of multiple sclerosis. Pharmacoepidemiol Drug Saf 2007; 16: 705–707.

    Article  PubMed  Google Scholar 

  43. Dolgin E . Pharmacogenetic tests yield bonus benefit: better drug adherence. Nat Med 2013; 19: 1354–1355.

    Article  PubMed  Google Scholar 

  44. Charland SL, Agatep BC, Herrera V, Schrader B, Frueh FW, Ryvkin M et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. Pharmacogenomics J 2013; 14: 272–280.

    Article  PubMed  Google Scholar 

  45. Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O . Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014; 13: 600–613.

    Article  CAS  PubMed  Google Scholar 

  46. Davis RL . The vaccine adverse event reporting system and vaccine safety research in the genomics era. Vaccine 2012; 30: 1162–1164.

    Article  PubMed  Google Scholar 

  47. Pellegrino P, Carnovale C, Cattaneo D, Perrone V, Antoniazzi S, Pozzi M et al. Pharmacovigilance knowledge in family paediatricians. Health Policy 2013; 113: 216–220.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Italian Medicines Agency (Agenzia Italiana del Farmaco) and the Ministry of Health (Ricerca Corrente 2014) to EC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Clementi.

Ethics declarations

Competing interests

The authors declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pellegrino, P., Falvella, F., Perrone, V. et al. The first steps towards the era of personalised vaccinology: predicting adverse reactions. Pharmacogenomics J 15, 284–287 (2015). https://doi.org/10.1038/tpj.2014.57

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2014.57

This article is cited by

Search

Quick links